TrumpRx’s 800-drug increase intensifies tariff threat facing generic drug manufacturers
Shares of U.S. generic drugmakers declined on Wednesday after President Donald Trump announced a schedule for new tariffs. Generic drugs brought into the U.S. could see tariffs reaching 200% starting in 2029. U.S. cash markets were shut.